| NCT ID | NCT00512694 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Systemic Lupus Erythematosus |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2007-07 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2007-07 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus * Patient of a rheumatologist at Duke University Medical Center Exclusion Criteria: * Inability to travel to Duke for follow-up visits * Inability to speak English * Not able to provide informed consent
Contact & Investigator
Megan E. B. Clowse, MD, MPH
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT00512694 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Lupus Erythematosus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00512694 currently recruiting?
Yes, NCT00512694 is actively recruiting participants. Contact the research team at laura.k.neil@duke.edu for enrollment information.
Where is the NCT00512694 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT00512694 clinical trial?
NCT00512694 is sponsored by Duke University. The principal investigator is Megan E. B. Clowse, MD, MPH at Duke University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.